BBLG stock news
This page provides real-time market news, earnings updates, and company announcements related to Bone Biologics Corp (BBLG).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-05-28 17:13 EST
Profound Medical Congratulates Texas Prostate on Achieving 100th TULSA Procedure Milestone
Finviz2026-03-27 11:48:42
Entera Bio Announces Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-27 20:09:39
Teva Gains Biosimilar Momentum with U.S. FDA Approval of PONLIMSI (denosumab-adet) and Dual Filing Acceptance for Biosimilar Candidate to Xolair (omalizumab)
Finviz2026-03-30 12:03:47
BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
Finviz2026-03-30 12:03:47
Once Upon a Farm Launches Five New Products Featuring Protein in Largest Portfolio Expansion to Date
Finviz2026-03-31 13:06:07
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod
Finviz2026-03-31 12:39:46
BioAtla Announces Share Consolidation
Finviz2026-03-31 20:09:09
Natural Grocers Expands Private-Label Line With Wellness Bath Tissue
Finviz2026-04-01 06:03:07
Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets
Finviz2026-04-01 12:03:45
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
Finviz2026-04-01 12:18:04
Concrete Pumping Holdings Announces Strategic Acquisition of Templant Hire Limited to Enter U.K. Temporary Power Market
Finviz2026-04-01 13:03:52
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
Finviz2026-04-01 21:15:48
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Finviz2026-04-02 12:03:42
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting
Finviz2026-04-06 11:34:00
Aclarion Announces Agreement with Weill Cornell Medicine
Finviz2026-04-08 12:03:52
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Finviz2026-04-08 13:18:12
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Finviz2026-04-13 12:03:59
Eli Lilly acquires biotech company Kelonia for $7 billion to strengthen its cancer treatment portfolio
格隆汇2026-04-21 01:18:28
Bioventus Inc stated in a filing with the SEC that expected adjustments to reimbursement policies related to the Exogen bone healing system are not anticipated to have a material impact on the company’s financial position for fiscal year 2026.
老虎证券2026-05-21 21:19:03
According to documents submitted to the U.S. Securities and Exchange Commission, the U.S. Food and Drug Administration completed the reclassification of Bioventus Inc.'s Exogen ultrasound bone healing system on April 16, 2026.
老虎证券2026-05-21 21:19:04
According to a document submitted to the U.S. Securities and Exchange Commission (SEC), the U.S. Centers for Medicare & Medicaid Services (CMS) has updated the Medicare reimbursement standards for non-invasive bone growth stimulators.
老虎证券2026-05-21 21:19:09
Once Upon a Farm Launches Five New Products Featuring Protein in Largest Portfolio Expansion to Date
Finviz2026-03-31 13:06:07
Tivic Receives Formal Request for Information from Ukrainian Ministry of Health Regarding Strategic Stockpiling of Entolimod
Finviz2026-03-31 12:39:46
BioAtla Announces Share Consolidation
Finviz2026-03-31 20:09:09
Natural Grocers Expands Private-Label Line With Wellness Bath Tissue
Finviz2026-04-01 06:03:07
Nanox Signs Distribution Agreement with Elite Surgical Technologies to Deploy Nanox.ARC in Key U.S. Markets
Finviz2026-04-01 12:03:45
Incision-Free, MRI-Guided Prostate Treatment with Profound's TULSA-PRO to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
Finviz2026-04-01 12:18:04
Concrete Pumping Holdings Announces Strategic Acquisition of Templant Hire Limited to Enter U.K. Temporary Power Market
Finviz2026-04-01 13:03:52
Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine
Finviz2026-04-01 21:15:48
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio
Finviz2026-04-02 12:03:42
Actinium Pharmaceuticals Announces New Pan-Tumor Preclinical Data for ATNM-400 in Solid Tumors and Differentiated Mechanism for Actimab-A in AML to be Presented at 2026 AACR Annual Meeting
Finviz2026-04-06 11:34:00
Aclarion Announces Agreement with Weill Cornell Medicine
Finviz2026-04-08 12:03:52
Longeveron Granted Chinese Patent for Potency Assay Methods for Assessing Human Mesenchymal Stem Cells (MSCs)
Finviz2026-04-08 13:18:12
Biotechs Racing to Translate Longevity Science Into Real Therapies -- And One Microcap Company Is Producing An Anti-Aging Protein From Genetically Modified, Encapsulated Cells
Finviz2026-04-10 13:57:05
AbbVie Showcases Late-Breaking Phase 2 Data for Mirvetuximab Soravtansine-gynx (ELAHERE) in Platinum-Sensitive Ovarian Cancer (PSOC) at SGO 2026
Finviz2026-04-12 11:18:39
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Finviz2026-04-13 12:03:59
Eli Lilly acquires biotech company Kelonia for $7 billion to strengthen its cancer treatment portfolio
格隆汇2026-04-21 01:18:28
Bioventus Inc stated in a filing with the SEC that expected adjustments to reimbursement policies related to the Exogen bone healing system are not anticipated to have a material impact on the company’s financial position for fiscal year 2026.
老虎证券2026-05-21 21:19:03
According to documents submitted to the U.S. Securities and Exchange Commission, the U.S. Food and Drug Administration completed the reclassification of Bioventus Inc.'s Exogen ultrasound bone healing system on April 16, 2026.
老虎证券2026-05-21 21:19:04
According to a document submitted to the U.S. Securities and Exchange Commission (SEC), the U.S. Centers for Medicare & Medicaid Services (CMS) has updated the Medicare reimbursement standards for non-invasive bone growth stimulators.
老虎证券2026-05-21 21:19:09
BBLG stock chart
BBLG stock detailsBBLG stock price change
On the last trading day, BBLG stock closed at 1.26 USD, with a price change of 3.28% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more